Lexicon Pharmaceuticals
Stock Forecast, Prediction & Price Target
Lexicon Pharmaceuticals Financial Estimates
Lexicon Pharmaceuticals Revenue Estimates
Lexicon Pharmaceuticals EBITDA Estimates
Lexicon Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $298K N/A | $139K -53.35% | $1.20M 766.18% | Avg: $98.47M Low: $49.26M High: $162.53M avg. 8079.26% | Avg: $196.59M Low: $100.87M High: $328.67M avg. 99.63% | Avg: $350.21M Low: $179.70M High: $585.49M avg. 78.13% | Avg: $532.74M Low: $273.36M High: $890.66M avg. 52.12% |
Net Income
% change YoY
| $-88.26M N/A | $-103.12M -16.83% | $-177.11M -71.74% | Avg: $-176.40M Low: $-165.84M High: $-46.43M avg. 0.40% | Avg: $-100.64M Low: $-172.48M High: $106.14M avg. 42.94% | Avg: $30.22M Low: $11.09M High: $56.61M avg. 130.02% | Avg: $139.31M Low: $51.13M High: $260.98M avg. 360.96% |
EBITDA
% change YoY
| $-86.95M N/A | $-99.16M -14.03% | $-163.46M -64.84% | Avg: $-68.17M Low: $-112.52M High: $-34.10M avg. 58.29% | Avg: $-136.10M Low: $-227.54M High: $-69.83M avg. -99.63% | Avg: $-242.45M Low: $-405.33M High: $-124.40M avg. -78.13% | Avg: $-368.82M Low: $-616.60M High: $-189.24M avg. -52.12% |
EPS
% change YoY
| -$0.61 N/A | -$0.62 -1.63% | -$0.8 -29.03% | Avg: -$0.61 Low: -$0.75 High: -$0.21 avg. 24.19% | Avg: -$0.3 Low: -$0.78 High: $0.48 avg. 51.12% | Avg: $0.14 Low: $0.05 High: $0.26 avg. 146.10% | Avg: $0.63 Low: $0.23 High: $1.18 avg. 360.96% |
Operating Expenses
% change YoY
| $87.38M N/A | $100.89M 15.46% | $172.86M 71.32% | Avg: $10.85B Low: $5.43B High: $17.92B avg. 6180.79% | Avg: $21.67B Low: $11.12B High: $36.23B avg. 99.63% | Avg: $38.61B Low: $19.81B High: $64.55B avg. 78.13% | Avg: $58.73B Low: $30.13B High: $98.19B avg. 52.12% |
FAQ
What is Lexicon Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 133.58% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -165.84M, average is -176.40M and high is -46.43M.
What is Lexicon Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 2077.28% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $49.26M, average is $98.47M and high is $162.53M.
What is Lexicon Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 145.59% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$0.75, average is -$0.61 and high is $-0.21.
What is the best performing analyst?
In the last twelve months analysts have been covering Lexicon Pharmaceuticals stock. The most successful analyst is Roanna Ruiz.